NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!
Contact Us
Contact Us

Nick McDonald

1 min read

AGC Biologics Appoints Jun Takami to General Manager/Site Head of Their Chiba, Japan Site

April 8, 2021 at 7:00 AM
Press Release
Read press release

2 min read

AGC Biologics to Present Their End-to-End Cell and Gene Therapy Offering at ARM’s Meeting on the Mediterranean Conference

April 5, 2021 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy

March 2, 2021 at 4:00 PM
Press Release
Read press release

1 min read

AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site

January 21, 2021 at 10:00 AM
Press Release
Read press release

3 min read

AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics’ Newly Approved Libmeldy™

January 4, 2021 at 6:30 AM
Press Release
Read press release

2 min read

Pierre Fabre Selects AGC Biologics as CDMO to Manufacture the Orphan Drug ER-004

December 21, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics to Expand Biopharmaceutical CDMO Capacity

November 30, 2020 at 3:10 PM
Press Release
Read press release

2 min read

AGC Biologics and Horizon Therapeutics plc Expand Partnership

October 29, 2020 at 12:00 PM
Press Release
Read press release

1 min read

MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition

October 27, 2020 at 4:00 PM
Press Release
Read press release

2 min read

AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions

October 15, 2020 at 5:00 AM
Press Release
Read press release
Prev 5 6 7 8 9 Next